Collaborations

The Laboratory collaborates with the following institutes by providing them with cell lines established from patients at PMH. This is done by growing the patient’s cancer cells in test tubes:

The Sanger Centre, Hinxton, England
Medical Research Council, Cambridge, England.
Institute of Cancer Research, Sutton, England.
Leukaemia Research Fund Centre, Royal Cancer Hospital, London
University of Cambridge, England
University of Surrey, England
University of Newcastle upon Tyne, Newcastle upon Tyne, England
The Netherlands Cancer Institute, The Netherlands
Institute of Genetics & Molecular Biology, Strasbourg, France
University La Laguna, Tenerife, Spain

Harvard Medical School, MA USA
Children’s Hospital of Philadelphia, PA USA
Ohio State University, Columbus, OH USA
National Human Genome Research Institute, Bethesda, MD USA
Roswell Park Cancer Institute, Buffalo, NY USA
University of North Carolina, Chapel Hill, USA
University of Southern California, USA
DNAX Research Institute, Palo Alto, USA
University of California, Los Angeles, USA
University of Chicago, Chicago, IL USA
The Children’s National Medical Center, Washington, DC USA
National Human Genome Research Institute, NIH, Bethesda, MD USA

Canterbury Health Labs, Christchurch, New Zealand

Kobe University, Japan

Victorian Cancer Cytogenetic Service, St. Vincent’s Hospital Melbourne
Women’s and Children’s Hospital, Adelaide
Peter MacCallum Institute, Melbourne
Sydney Children's Hospital, Sydney
Westmead Hospital, Sydney
Royal Brisbane Hospital, Brisbane
Queensland Institute of Medical Research, Brisbane
Institute of Medical and Veterinary Science, Adelaide

Princess Margaret Hospital for Children, Perth
WA Centre for Pathology and Medical Research, Perth
Royal Perth Hospital, Perth
QEII Medical Centre, Perth
King Edward Memorial Hospital, Perth
Dept. Biochemistry, University of WA, Perth

Collaboration on genetic markers (error in genetic materials in cancer cells only) and treatment of leukaemia:

Children’s Oncology Group, Los Angeles, USA